PEGS Summit - 2019 Archive

2019 Archived Content

View By:

Topic

Date

▶ Learn More

Display of Antibodies

Antibodies for Cancer Therapy

Improving Immunotherapy Efficacy and Safety

Difficult-to-Express Proteins

Characterization of Biotherapeutics

Immunogenicity Case Studies and Clinical Management

Fusion Protein Therapeutics

Emerging Indications for Therapeutic Antibodies

Engineering Antibodies

Advancing Bispecific Antibodies and Combination Therapy to the Clinic

CAR Ts, TCRs and TILs

Optimizing Protein Expression

Biophysical and Structural Analysis

Immunogenicity Assessment and Regulatory Approval of Biologics

Engineering Antibody-Drug Conjugates

Oncolytic Viral Therapy

Engineering Bispecific Antibodies

Clinical Progress of Antibody-Drug Conjugates

Agonist Immunotherapy Targets

Protein Expression System Engineering

Analytical Support for Drug Product Development

Optimizing Bioassays for Biologics

PEGS: The Essential Protein Engineering Summit is the industry’s preeminent event that inspires innovative biotherapeutic protein drug development.

The PEGS Summit has celebrated record growth for ten consecutive years with over 2,600 industry professionals in attendance and is on track to set another new record this spring.

PEGS Boston 2019 will host more than 400 lectures, panels, tutorials and round-table discussions, along with 150+ exhibitors, and 300 research posters on display in the exhibit hall. The speaker lineup includes world-renowned experts, visionaries, and influencers from top pharma, biotech, academic, and government institutions.

PLENARY KEYNOTE SESSION

Leena Gandhi, MD, PhD,
Vice President, Immuno-Oncology Medical Development, Lilly Oncology

keynote-headshot-hastie-400x400

Young Scientist Keynote
Kathryn Hastie, PhD,
Staff Scientist, Immunology and Microbiology, The Scripps Research Institute

""PEGS was highly anticipated and did not disappoint. Industry speakers shared their experience on the regulatory and clinical pathways for bioassay development. PEGS brought together leading thinkers to discuss how to make the cross-functional matrix work in speeding product to market."

Principal Scientific Liaison, USP

"The PEGS meeting is an outstanding conference, which continues to provide a uniquely high level of technical discourse on the development of protein therapeutics, which has become harder to find at other large conferences.”

Chief Scientific Officer, Shattuck Labs, Inc.